Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ingevity Corp | Director | Common Stock | 22.3K | $991K | $44.44 | Apr 24, 2024 | Direct |
H-CYTE, INC. | 10%+ Owner | COMMON STOCK | 8.32M | $117K | $0.01 | Mar 21, 2022 | Indirect |
H-CYTE, INC. | 10%+ Owner | STOCK PURCHASE WARRANTS | 8.32M | Mar 21, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NGVT | Ingevity Corp | Apr 24, 2024 | 1 | $0 | 4 | Apr 26, 2024 | Director |
NGVT | Ingevity Corp | Apr 28, 2023 | 1 | $0 | 4 | May 2, 2023 | Director |
NGVT | Ingevity Corp | Apr 28, 2022 | 1 | $0 | 4 | May 2, 2022 | Director |
HCYT | H-CYTE, INC. | Mar 21, 2022 | 3 | $233K | 4 | Mar 23, 2022 | 10%+ Owner |
HCYT | H-CYTE, INC. | Sep 24, 2020 | 0 | $0 | 3 | Feb 17, 2022 | 10%+ Owner |